Rank | Gene Set | Z-score |
---|---|---|
1 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 9.14944032 |
2 | sphingoid metabolic process (GO:0046519) | 7.64068438 |
3 | adhesion of symbiont to host cell (GO:0044650) | 7.56982615 |
4 | virion attachment to host cell (GO:0019062) | 7.56982615 |
5 | hemidesmosome assembly (GO:0031581) | 6.99841406 |
6 | regulation of water loss via skin (GO:0033561) | 6.99620512 |
7 | establishment of skin barrier (GO:0061436) | 6.74850614 |
8 | antigen processing and presentation of endogenous antigen (GO:0019883) | 6.62401856 |
9 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 6.26184181 |
10 | negative regulation of cell killing (GO:0031342) | 6.26184181 |
11 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 6.12197797 |
12 | positive regulation by symbiont of host defense response (GO:0052509) | 6.03046412 |
13 | modulation by symbiont of host defense response (GO:0052031) | 6.03046412 |
14 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 6.03046412 |
15 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 6.03046412 |
16 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 6.03046412 |
17 | modulation by symbiont of host immune response (GO:0052553) | 6.03046412 |
18 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.99832471 |
19 | adhesion of symbiont to host (GO:0044406) | 5.92196095 |
20 | regulation of natural killer cell differentiation (GO:0032823) | 5.88077930 |
21 | neutrophil activation involved in immune response (GO:0002283) | 5.77643002 |
22 | keratinocyte differentiation (GO:0030216) | 5.72430503 |
23 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.46840514 |
24 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.46840514 |
25 | keratinization (GO:0031424) | 5.46412749 |
26 | response to peptidoglycan (GO:0032494) | 5.35840635 |
27 | sphingosine metabolic process (GO:0006670) | 5.35347115 |
28 | diol metabolic process (GO:0034311) | 5.27407774 |
29 | macrophage activation involved in immune response (GO:0002281) | 5.14415993 |
30 | collecting duct development (GO:0072044) | 5.11033688 |
31 | regulation of glomerular filtration (GO:0003093) | 4.98331558 |
32 | cellular response to interferon-alpha (GO:0035457) | 4.89601841 |
33 | multicellular organismal water homeostasis (GO:0050891) | 4.88709951 |
34 | regulation of ruffle assembly (GO:1900027) | 4.85026552 |
35 | detection of external biotic stimulus (GO:0098581) | 4.78120791 |
36 | positive regulation of natural killer cell differentiation (GO:0032825) | 4.72621873 |
37 | negative regulation of interleukin-12 production (GO:0032695) | 4.72085662 |
38 | negative regulation of activin receptor signaling pathway (GO:0032926) | 4.68322737 |
39 | detection of bacterium (GO:0016045) | 4.60221704 |
40 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.58148525 |
41 | detection of molecule of bacterial origin (GO:0032490) | 4.50425586 |
42 | epidermal cell differentiation (GO:0009913) | 4.50266656 |
43 | cellular extravasation (GO:0045123) | 4.48983797 |
44 | epidermis development (GO:0008544) | 4.45454414 |
45 | leukocyte aggregation (GO:0070486) | 4.43871652 |
46 | regulation of gamma-delta T cell activation (GO:0046643) | 4.33828256 |
47 | positive regulation of mast cell activation (GO:0033005) | 4.30277268 |
48 | detection of biotic stimulus (GO:0009595) | 4.24474014 |
49 | regulation of mast cell degranulation (GO:0043304) | 4.22489775 |
50 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 4.21152674 |
51 | respiratory burst (GO:0045730) | 4.20366279 |
52 | renal system process involved in regulation of blood volume (GO:0001977) | 4.16882646 |
53 | regulation of transforming growth factor beta2 production (GO:0032909) | 4.11585880 |
54 | water homeostasis (GO:0030104) | 4.10258888 |
55 | microglial cell activation (GO:0001774) | 4.09890078 |
56 | intermediate filament organization (GO:0045109) | 4.08575746 |
57 | neutrophil activation (GO:0042119) | 4.08557506 |
58 | detection of other organism (GO:0098543) | 4.08528247 |
59 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.07673377 |
60 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.99633211 |
61 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.97622858 |
62 | immunoglobulin mediated immune response (GO:0016064) | 3.96063498 |
63 | response to host immune response (GO:0052572) | 3.96057428 |
64 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.96057428 |
65 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.93930521 |
66 | ventricular cardiac muscle cell action potential (GO:0086005) | 3.93825273 |
67 | macrophage activation (GO:0042116) | 3.92510242 |
68 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.91972110 |
69 | regulation of leukocyte degranulation (GO:0043300) | 3.85845743 |
70 | negative regulation of T cell mediated immunity (GO:0002710) | 3.83605436 |
71 | myeloid cell activation involved in immune response (GO:0002275) | 3.82424467 |
72 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.80808724 |
73 | regulation of cardioblast proliferation (GO:0003264) | 3.78760069 |
74 | regulation of secondary heart field cardioblast proliferation (GO:0003266) | 3.78760069 |
75 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.78749055 |
76 | peptide cross-linking (GO:0018149) | 3.78298252 |
77 | granulocyte activation (GO:0036230) | 3.76138279 |
78 | regulation of mast cell activation (GO:0033003) | 3.75328625 |
79 | keratinocyte proliferation (GO:0043616) | 3.74748797 |
80 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.71857960 |
81 | negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804) | 3.69870751 |
82 | response to host (GO:0075136) | 3.65650561 |
83 | response to host defenses (GO:0052200) | 3.65650561 |
84 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.65650561 |
85 | positive regulation of mast cell degranulation (GO:0043306) | 3.65107184 |
86 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.65107184 |
87 | neutrophil mediated immunity (GO:0002446) | 3.64714890 |
88 | gland morphogenesis (GO:0022612) | 3.61517621 |
89 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.53654396 |
90 | response to muramyl dipeptide (GO:0032495) | 3.50637088 |
91 | response to phenylpropanoid (GO:0080184) | 3.48354104 |
92 | cellular response to vitamin (GO:0071295) | 3.47570312 |
93 | negative regulation of kidney development (GO:0090185) | 3.43445067 |
94 | regulation of T cell tolerance induction (GO:0002664) | 3.43224672 |
95 | regulation of tolerance induction (GO:0002643) | 3.43165785 |
96 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.43046704 |
97 | positive regulation of antigen processing and presentation (GO:0002579) | 3.40053599 |
98 | regulation of somitogenesis (GO:0014807) | 3.37707878 |
99 | skin morphogenesis (GO:0043589) | 3.37689165 |
100 | regulation of regulated secretory pathway (GO:1903305) | 3.36410406 |
101 | hair follicle development (GO:0001942) | 3.35404001 |
102 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.34530678 |
103 | molting cycle (GO:0042303) | 3.34179303 |
104 | hair cycle (GO:0042633) | 3.34179303 |
105 | skin development (GO:0043588) | 3.33252576 |
106 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 3.33127742 |
107 | regulation of hair follicle development (GO:0051797) | 3.31234914 |
108 | response to interferon-alpha (GO:0035455) | 3.30516039 |
109 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.29239918 |
110 | * thymus development (GO:0048538) | 3.28888742 |
111 | cyclooxygenase pathway (GO:0019371) | 3.26885620 |
112 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.26373230 |
113 | regulation of cell proliferation involved in kidney development (GO:1901722) | 3.23732309 |
114 | cell communication involved in cardiac conduction (GO:0086065) | 3.22985729 |
115 | renal system process involved in regulation of systemic arterial blood pressure (GO:0003071) | 3.21774379 |
116 | B cell receptor signaling pathway (GO:0050853) | 3.18080345 |
117 | response to interleukin-15 (GO:0070672) | 3.17866268 |
118 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 3.16098530 |
119 | leukocyte degranulation (GO:0043299) | 3.14895251 |
120 | activated T cell proliferation (GO:0050798) | 3.13821592 |
121 | phospholipid scrambling (GO:0017121) | 3.13262841 |
122 | regulation of heart rate by cardiac conduction (GO:0086091) | 3.12559326 |
123 | negative regulation of phagocytosis (GO:0050765) | 3.11820433 |
124 | myeloid leukocyte mediated immunity (GO:0002444) | 3.11524355 |
125 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.11445860 |
126 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.09154963 |
127 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.05577759 |
128 | negative regulation of interferon-gamma production (GO:0032689) | 3.05102088 |
129 | regulation of transforming growth factor beta1 production (GO:0032908) | 3.04864334 |
130 | B cell mediated immunity (GO:0019724) | 3.04552696 |
131 | regulation of B cell differentiation (GO:0045577) | 3.03638728 |
132 | positive regulation of B cell differentiation (GO:0045579) | 3.02890941 |
133 | positive regulation of leukocyte degranulation (GO:0043302) | 2.99255242 |
134 | negative regulation of fibroblast apoptotic process (GO:2000270) | 2.96857142 |
135 | bone morphogenesis (GO:0060349) | 2.96124239 |
136 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.96021871 |
137 | defense response to protozoan (GO:0042832) | 2.94871580 |
138 | negative regulation of type 2 immune response (GO:0002829) | 2.94499946 |
139 | positive thymic T cell selection (GO:0045059) | 2.93514599 |
140 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.93272879 |
141 | dendritic cell migration (GO:0036336) | 2.92749329 |
142 | positive regulation of regulated secretory pathway (GO:1903307) | 2.90423041 |
143 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.89295697 |
144 | negative thymic T cell selection (GO:0045060) | 2.88614160 |
145 | regulation of phospholipase A2 activity (GO:0032429) | 2.88446335 |
146 | T cell selection (GO:0045058) | 2.88437750 |
147 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.88291313 |
148 | intermediate filament cytoskeleton organization (GO:0045104) | 2.88085678 |
149 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.87698702 |
150 | negative regulation of keratinocyte proliferation (GO:0010839) | 2.87387096 |
151 | negative regulation of interleukin-6 production (GO:0032715) | 2.86623523 |
152 | germinal center formation (GO:0002467) | 2.86232954 |
153 | negative regulation of cell fate specification (GO:0009996) | 2.85166251 |
154 | myeloid leukocyte activation (GO:0002274) | 2.84406350 |
155 | positive regulation of tolerance induction (GO:0002645) | 2.83743652 |
156 | CD4-positive, alpha-beta T cell differentiation (GO:0043367) | 2.80989222 |
157 | cellular response to interleukin-15 (GO:0071350) | 2.80813433 |
158 | intermediate filament-based process (GO:0045103) | 2.79755728 |
159 | negative regulation of innate immune response (GO:0045824) | 2.79562400 |
160 | dendritic cell chemotaxis (GO:0002407) | 2.79263947 |
161 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.78492128 |
162 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.78492128 |
163 | extracellular matrix assembly (GO:0085029) | 2.76065759 |
164 | regulation of antigen processing and presentation (GO:0002577) | 2.75407954 |
165 | chemical homeostasis within a tissue (GO:0048875) | 2.74595680 |
166 | regulation of Cdc42 GTPase activity (GO:0043088) | 2.74114240 |
167 | positive regulation of Rho protein signal transduction (GO:0035025) | 2.72869487 |
168 | hair cycle process (GO:0022405) | 2.72246853 |
169 | molting cycle process (GO:0022404) | 2.72246853 |
170 | thymic T cell selection (GO:0045061) | 2.68543589 |
171 | long-chain fatty acid biosynthetic process (GO:0042759) | 2.59811023 |
172 | regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803) | 2.59743309 |
173 | tight junction assembly (GO:0070830) | 2.59152544 |
174 | positive regulation of glomerulus development (GO:0090193) | 2.58387473 |
175 | regulation of branching involved in prostate gland morphogenesis (GO:0060687) | 2.58114727 |
176 | mesenchymal cell differentiation involved in kidney development (GO:0072161) | 2.55526067 |
177 | mesenchymal cell differentiation involved in renal system development (GO:2001012) | 2.55526067 |
178 | regulation of transforming growth factor beta production (GO:0071634) | 2.55274407 |
179 | regulation of cell proliferation involved in heart morphogenesis (GO:2000136) | 2.54833034 |
180 | regulation of hair cycle (GO:0042634) | 2.54650238 |
181 | epithelial cell fate commitment (GO:0072148) | 2.53043285 |
182 | positive regulation of mitochondrial membrane permeability (GO:0035794) | 2.52587427 |
183 | negative regulation of biomineral tissue development (GO:0070168) | 2.51978649 |
184 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.51302947 |
185 | planar cell polarity pathway involved in neural tube closure (GO:0090179) | 2.50984604 |
186 | regulation of keratinocyte proliferation (GO:0010837) | 2.50603742 |
187 | sphingolipid biosynthetic process (GO:0030148) | 2.50578553 |
188 | cardiac conduction (GO:0061337) | 2.49405203 |
189 | atrioventricular valve morphogenesis (GO:0003181) | 2.49021190 |
190 | CD4-positive, alpha-beta T cell activation (GO:0035710) | 2.48218513 |
191 | intestinal epithelial cell development (GO:0060576) | 2.46812419 |
192 | desmosome organization (GO:0002934) | 11.9685468 |
Rank | Gene Set | Z-score |
---|---|---|
1 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 6.50675163 |
2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.59439959 |
3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.37023775 |
4 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.60536612 |
5 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.60504549 |
6 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.44906950 |
7 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.39201480 |
8 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.93920252 |
9 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.88158363 |
10 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.73977958 |
11 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.71082150 |
12 | SPI1_23127762_ChIP-Seq_K562_Human | 2.69825123 |
13 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.66385237 |
14 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 2.63498581 |
15 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.61458272 |
16 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.60474574 |
17 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.47338917 |
18 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.40324509 |
19 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.40230101 |
20 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 2.39895210 |
21 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.37498322 |
22 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.37492519 |
23 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.36194243 |
24 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.31160804 |
25 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.29760893 |
26 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.25129893 |
27 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.22555205 |
28 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.18550412 |
29 | MAF_26560356_Chip-Seq_TH1_Human | 2.17983477 |
30 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 2.17732078 |
31 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.12397256 |
32 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.05915279 |
33 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.04248493 |
34 | MYB_26560356_Chip-Seq_TH2_Human | 2.02950961 |
35 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 10.7773839 |
36 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.99110127 |
37 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.98100781 |
38 | MYC_22102868_ChIP-Seq_BL_Human | 1.97632136 |
39 | UTX_26944678_Chip-Seq_JUKART_Human | 1.94515149 |
40 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.91938061 |
41 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.91583201 |
42 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.90336070 |
43 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.83869778 |
44 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.79657264 |
45 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.77641269 |
46 | MYB_26560356_Chip-Seq_TH1_Human | 1.76463229 |
47 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.75358258 |
48 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.74742765 |
49 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.74047802 |
50 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.71578687 |
51 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.71578687 |
52 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.68870778 |
53 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.67820600 |
54 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.67483559 |
55 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.66478348 |
56 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.60183899 |
57 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.59408269 |
58 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.59113917 |
59 | MAF_26560356_Chip-Seq_TH2_Human | 1.57375202 |
60 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.55493274 |
61 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.53122540 |
62 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.48781132 |
63 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.48732375 |
64 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.47042452 |
65 | CJUN_26792858_Chip-Seq_BT549_Human | 1.46593285 |
66 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.45624087 |
67 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.45449674 |
68 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.44549705 |
69 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.44346371 |
70 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.43324507 |
71 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.43199186 |
72 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.42269712 |
73 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.39477574 |
74 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.38464028 |
75 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.38288047 |
76 | TP63_23658742_ChIP-Seq_EP156T_Human | 1.38099314 |
77 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.37980129 |
78 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.36814724 |
79 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.36228284 |
80 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.35866573 |
81 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.35401219 |
82 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.35131966 |
83 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.32563150 |
84 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.32284281 |
85 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.31062339 |
86 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.31062339 |
87 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.30531063 |
88 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.30104232 |
89 | * PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.29683230 |
90 | GATA1_19941826_ChIP-Seq_K562_Human | 1.28276856 |
91 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.25017813 |
92 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.24913258 |
93 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.24747337 |
94 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.24053462 |
95 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.23751227 |
96 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.23612424 |
97 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.21805286 |
98 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.21586002 |
99 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.21350678 |
100 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.20118052 |
101 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.19235120 |
102 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.18971079 |
103 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.18731882 |
104 | TP53_16413492_ChIP-PET_HCT116_Human | 1.17126331 |
105 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.16072602 |
106 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.15740833 |
107 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.15473824 |
108 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.15436665 |
109 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.15158812 |
110 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.15000287 |
111 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.13896826 |
112 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.13891024 |
113 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.12742989 |
114 | GATA3_26560356_Chip-Seq_TH2_Human | 1.11518368 |
115 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.10992435 |
116 | RXR_22108803_ChIP-Seq_LS180_Human | 1.08113197 |
117 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.07337927 |
118 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.07228654 |
119 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.06989083 |
120 | GATA1_22025678_ChIP-Seq_K562_Human | 1.06573846 |
121 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.06193519 |
122 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.05864339 |
123 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.05168014 |
124 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.04982201 |
125 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.04405495 |
126 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.04385553 |
127 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.03808233 |
128 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.03739255 |
129 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.02819044 |
130 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.02784157 |
131 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.01957821 |
132 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.01673307 |
133 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.00931701 |
134 | KLF5_25053715_ChIP-Seq_YYC3_Human | 1.00787517 |
135 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.00660073 |
136 | GATA2_19941826_ChIP-Seq_K562_Human | 1.00649381 |
137 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 1.00212211 |
138 | * PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.00170983 |
139 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 0.96854278 |
140 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.96853447 |
141 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.96085686 |
142 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.95757737 |
143 | * ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.95329184 |
144 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.95229327 |
145 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.94958083 |
146 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.92777912 |
147 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.91734526 |
148 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.91629592 |
149 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.90757214 |
150 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.89372159 |
151 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.89372159 |
152 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.89140309 |
153 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.88197997 |
154 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.88173423 |
155 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.87668116 |
156 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 0.87440948 |
157 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.87411539 |
158 | * TCF4_22108803_ChIP-Seq_LS180_Human | 0.86631237 |
159 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.84904074 |
160 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.84318876 |
161 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.83321112 |
162 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.83151627 |
163 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.82866620 |
164 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.82586681 |
165 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.82377892 |
166 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.82093014 |
167 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.81563541 |
168 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.81532741 |
169 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.81502109 |
170 | KDM2B_26808549_Chip-Seq_K562_Human | 0.81013655 |
171 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.80065020 |
172 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.80022400 |
173 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.79257952 |
174 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 0.79164015 |
175 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.78826442 |
176 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.77559708 |
177 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.77234271 |
178 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.76814847 |
179 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 0.76332617 |
180 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.75621309 |
181 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 0.75593810 |
182 | * BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.75568552 |
183 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.75413858 |
184 | ATF3_27146783_Chip-Seq_COLON_Human | 0.74814376 |
185 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.73879684 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002254_reproductive_system_inflammat | 6.84171839 |
2 | MP0002796_impaired_skin_barrier | 5.26231555 |
3 | MP0003724_increased_susceptibility_to | 4.72448980 |
4 | MP0010234_abnormal_vibrissa_follicle | 4.49962142 |
5 | MP0003941_abnormal_skin_development | 4.48172379 |
6 | MP0003436_decreased_susceptibility_to | 4.21812576 |
7 | MP0001346_abnormal_lacrimal_gland | 3.91551022 |
8 | MP0003453_abnormal_keratinocyte_physiol | 3.64240115 |
9 | MP0005275_abnormal_skin_tensile | 3.47443713 |
10 | MP0003303_peritoneal_inflammation | 3.46937419 |
11 | MP0005367_renal/urinary_system_phenotyp | 3.33651812 |
12 | MP0000516_abnormal_urinary_system | 3.33651812 |
13 | MP0002098_abnormal_vibrissa_morphology | 3.25324726 |
14 | MP0002419_abnormal_innate_immunity | 3.22810406 |
15 | MP0006082_CNS_inflammation | 3.07981778 |
16 | MP0002060_abnormal_skin_morphology | 3.01736687 |
17 | MP0005501_abnormal_skin_physiology | 2.97298621 |
18 | MP0005451_abnormal_body_composition | 2.93543348 |
19 | MP0005025_abnormal_response_to | 2.84733668 |
20 | MP0002009_preneoplasia | 2.74826823 |
21 | MP0010678_abnormal_skin_adnexa | 2.74018228 |
22 | MP0009785_altered_susceptibility_to | 2.72289530 |
23 | MP0001800_abnormal_humoral_immune | 2.70508334 |
24 | MP0005000_abnormal_immune_tolerance | 2.68747198 |
25 | MP0000579_abnormal_nail_morphology | 2.63728254 |
26 | MP0000383_abnormal_hair_follicle | 2.61673807 |
27 | MP0003300_gastrointestinal_ulcer | 2.57944851 |
28 | MP0001216_abnormal_epidermal_layer | 2.48751864 |
29 | MP0002723_abnormal_immune_serum | 2.44900424 |
30 | MP0002452_abnormal_antigen_presenting | 2.43681816 |
31 | MP0002420_abnormal_adaptive_immunity | 2.39576706 |
32 | MP0004381_abnormal_hair_follicle | 2.37715214 |
33 | MP0001819_abnormal_immune_cell | 2.36834991 |
34 | MP0000377_abnormal_hair_follicle | 2.34345772 |
35 | MP0003828_pulmonary_edema | 2.31707400 |
36 | MP0000685_abnormal_immune_system | 2.28846954 |
37 | MP0010771_integument_phenotype | 2.22973536 |
38 | MP0002148_abnormal_hypersensitivity_rea | 2.20553630 |
39 | MP0001533_abnormal_skeleton_physiology | 2.18440516 |
40 | MP0000647_abnormal_sebaceous_gland | 2.17689903 |
41 | MP0003172_abnormal_lysosome_physiology | 2.16854399 |
42 | MP0004947_skin_inflammation | 2.12908544 |
43 | MP0005464_abnormal_platelet_physiology | 2.09831397 |
44 | MP0000467_abnormal_esophagus_morphology | 2.03479615 |
45 | MP0008260_abnormal_autophagy | 2.02092102 |
46 | MP0002405_respiratory_system_inflammati | 2.00357758 |
47 | MP0005058_abnormal_lysosome_morphology | 1.94831475 |
48 | MP0002132_abnormal_respiratory_system | 1.83186660 |
49 | MP0000465_gastrointestinal_hemorrhage | 1.80376481 |
50 | MP0010386_abnormal_urinary_bladder | 1.79248031 |
51 | MP0002234_abnormal_pharynx_morphology | 1.73713298 |
52 | MP0000716_abnormal_immune_system | 1.72693286 |
53 | MP0003011_delayed_dark_adaptation | 1.69971190 |
54 | MP0002398_abnormal_bone_marrow | 1.68772552 |
55 | MP0000762_abnormal_tongue_morphology | 1.68510761 |
56 | MP0001845_abnormal_inflammatory_respons | 1.67524163 |
57 | MP0010155_abnormal_intestine_physiology | 1.64013940 |
58 | MP0000427_abnormal_hair_cycle | 1.60618104 |
59 | MP0003690_abnormal_glial_cell | 1.59428768 |
60 | MP0004883_abnormal_blood_vessel | 1.57987230 |
61 | MP0009333_abnormal_splenocyte_physiolog | 1.55177418 |
62 | MP0002277_abnormal_respiratory_mucosa | 1.54335224 |
63 | MP0002998_abnormal_bone_remodeling | 1.53159870 |
64 | MP0000689_abnormal_spleen_morphology | 1.46310212 |
65 | * MP0002722_abnormal_immune_system | 1.41145355 |
66 | MP0003566_abnormal_cell_adhesion | 1.40676022 |
67 | MP0008469_abnormal_protein_level | 1.40394821 |
68 | MP0000566_synostosis | 1.39945887 |
69 | MP0003075_altered_response_to | 1.38976599 |
70 | MP0000537_abnormal_urethra_morphology | 1.38471236 |
71 | MP0000538_abnormal_urinary_bladder | 1.35626283 |
72 | MP0002429_abnormal_blood_cell | 1.33761956 |
73 | MP0001835_abnormal_antigen_presentation | 1.32677441 |
74 | MP0003866_abnormal_defecation | 1.31992709 |
75 | MP0005023_abnormal_wound_healing | 1.28092112 |
76 | MP0005397_hematopoietic_system_phenotyp | 1.27265312 |
77 | MP0001545_abnormal_hematopoietic_system | 1.27265312 |
78 | MP0009764_decreased_sensitivity_to | 1.26736348 |
79 | * MP0000703_abnormal_thymus_morphology | 1.18627829 |
80 | MP0009931_abnormal_skin_appearance | 1.18528048 |
81 | MP0003705_abnormal_hypodermis_morpholog | 1.17775752 |
82 | MP0003183_abnormal_peptide_metabolism | 1.17439508 |
83 | MP0000343_altered_response_to | 1.15916828 |
84 | MP0001191_abnormal_skin_condition | 1.15906113 |
85 | MP0005164_abnormal_response_to | 1.14848698 |
86 | MP0000015_abnormal_ear_pigmentation | 1.14637304 |
87 | MP0000613_abnormal_salivary_gland | 1.14574239 |
88 | MP0001851_eye_inflammation | 1.14300832 |
89 | MP0005623_abnormal_meninges_morphology | 1.13662265 |
90 | MP0001849_ear_inflammation | 1.13323471 |
91 | MP0002938_white_spotting | 1.13312378 |
92 | MP0005166_decreased_susceptibility_to | 1.10910505 |
93 | MP0000733_abnormal_muscle_development | 1.10369166 |
94 | MP0004264_abnormal_extraembryonic_tissu | 1.04381808 |
95 | MP0005671_abnormal_response_to | 1.03751934 |
96 | MP0000604_amyloidosis | 1.03276929 |
97 | MP0002396_abnormal_hematopoietic_system | 1.01988404 |
98 | MP0002166_altered_tumor_susceptibility | 1.01242088 |
99 | MP0009250_abnormal_appendicular_skeleto | 0.99184541 |
100 | MP0003448_altered_tumor_morphology | 0.98664340 |
101 | MP0003763_abnormal_thymus_physiology | 0.96044776 |
102 | MP0005508_abnormal_skeleton_morphology | 0.95576724 |
103 | MP0001958_emphysema | 0.94706454 |
104 | MP0010030_abnormal_orbit_morphology | 0.94457461 |
105 | MP0004782_abnormal_surfactant_physiolog | 0.94255753 |
106 | MP0005075_abnormal_melanosome_morpholog | 0.93065989 |
107 | MP0004510_myositis | 0.92007090 |
108 | MP0001790_abnormal_immune_system | 0.91931130 |
109 | MP0005387_immune_system_phenotype | 0.91931130 |
110 | MP0001340_abnormal_eyelid_morphology | 0.90328749 |
111 | MP0004272_abnormal_basement_membrane | 0.89523972 |
112 | MP0001243_abnormal_dermal_layer | 0.88743776 |
113 | MP0000678_abnormal_parathyroid_gland | 0.86988729 |
114 | MP0002177_abnormal_outer_ear | 0.86554930 |
115 | MP0000367_abnormal_coat/_hair | 0.86389043 |
116 | MP0009379_abnormal_foot_pigmentation | 0.85948224 |
117 | MP0001348_abnormal_lacrimal_gland | 0.85242797 |
118 | MP0001986_abnormal_taste_sensitivity | 0.84396293 |
119 | MP0002133_abnormal_respiratory_system | 0.83971493 |
120 | MP0005388_respiratory_system_phenotype | 0.83971493 |
121 | MP0002249_abnormal_larynx_morphology | 0.82891867 |
122 | MP0002233_abnormal_nose_morphology | 0.82221069 |
123 | MP0002095_abnormal_skin_pigmentation | 0.81892155 |
124 | MP0001270_distended_abdomen | 0.81392039 |
125 | MP0006054_spinal_hemorrhage | 0.80418870 |
126 | MP0005310_abnormal_salivary_gland | 0.78569260 |
127 | MP0009763_increased_sensitivity_to | 0.78483176 |
128 | MP0003755_abnormal_palate_morphology | 0.78401499 |
129 | MP0002932_abnormal_joint_morphology | 0.78094001 |
130 | MP0004185_abnormal_adipocyte_glucose | 0.77950890 |
131 | MP0002876_abnormal_thyroid_physiology | 0.77171418 |
132 | MP0000858_altered_metastatic_potential | 0.75260542 |
133 | MP0005083_abnormal_biliary_tract | 0.73230767 |
134 | MP0001663_abnormal_digestive_system | 0.70896775 |
135 | MP0005174_abnormal_tail_pigmentation | 0.70674661 |
136 | MP0003091_abnormal_cell_migration | 0.70537496 |
137 | MP0002006_tumorigenesis | 0.70217794 |
138 | MP0003806_abnormal_nucleotide_metabolis | 0.70037981 |
139 | MP0003638_abnormal_response/metabolism_ | 0.70026472 |
140 | MP0003795_abnormal_bone_structure | 0.69103026 |
141 | MP0000627_abnormal_mammary_gland | 0.66889793 |
142 | MP0002111_abnormal_tail_morphology | 0.66639520 |
143 | MP0003656_abnormal_erythrocyte_physiolo | 0.65173385 |
144 | MP0000249_abnormal_blood_vessel | 0.61772611 |
145 | MP0004130_abnormal_muscle_cell | 0.61131580 |
146 | MP0008874_decreased_physiological_sensi | 0.61127548 |
147 | MP0000920_abnormal_myelination | 0.60964365 |
148 | MP0000490_abnormal_crypts_of | 0.60811891 |
149 | MP0003385_abnormal_body_wall | 0.60473980 |
150 | MP0003329_amyloid_beta_deposits | 0.60032037 |
151 | MP0000049_abnormal_middle_ear | 0.59593313 |
152 | MP0001177_atelectasis | 0.59587476 |
153 | MP0003191_abnormal_cellular_cholesterol | 0.59354723 |
154 | MP0009384_cardiac_valve_regurgitation | 0.58581717 |
155 | MP0002933_joint_inflammation | 0.57530226 |
156 | MP0000681_abnormal_thyroid_gland | 0.57272173 |
157 | MP0008789_abnormal_olfactory_epithelium | 0.56999975 |
158 | MP0005076_abnormal_cell_differentiation | 0.56951975 |
159 | MP0000569_abnormal_digit_pigmentation | 0.56486147 |
160 | MP0003045_fibrosis | 0.55367484 |
161 | MP0009765_abnormal_xenobiotic_induced | 0.55069140 |
162 | MP0000470_abnormal_stomach_morphology | 0.52606759 |
163 | MP0008004_abnormal_stomach_pH | 0.52249303 |
164 | MP0001853_heart_inflammation | 0.52200481 |
165 | MP0005390_skeleton_phenotype | 0.51969950 |
166 | MP0009278_abnormal_bone_marrow | 0.51888402 |
167 | MP0001873_stomach_inflammation | 0.50986830 |
168 | MP0000163_abnormal_cartilage_morphology | 0.43901120 |
169 | MP0003935_abnormal_craniofacial_develop | 0.43768030 |
170 | MP0001299_abnormal_eye_distance/ | 0.43423868 |
171 | MP0002697_abnormal_eye_size | 0.42294496 |
172 | MP0004019_abnormal_vitamin_homeostasis | 0.41716303 |
173 | MP0005503_abnormal_tendon_morphology | 0.41217500 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Right ventricular cardiomyopathy (HP:0011663) | 8.81843540 |
2 | Recurrent abscess formation (HP:0002722) | 6.28202919 |
3 | Lip pit (HP:0100267) | 6.26562593 |
4 | Recurrent bacterial skin infections (HP:0005406) | 6.25365625 |
5 | Abnormality of macrophages (HP:0004311) | 5.83606033 |
6 | Onycholysis (HP:0001806) | 5.79209384 |
7 | Hypotrichosis (HP:0001006) | 5.76500579 |
8 | Plantar hyperkeratosis (HP:0007556) | 5.73048815 |
9 | Alacrima (HP:0000522) | 5.60535266 |
10 | Nasolacrimal duct obstruction (HP:0000579) | 5.53602285 |
11 | Woolly hair (HP:0002224) | 5.51419372 |
12 | Myositis (HP:0100614) | 5.44870203 |
13 | Recurrent gram-negative bacterial infections (HP:0005420) | 5.26536718 |
14 | Orchitis (HP:0100796) | 5.10060238 |
15 | Abnormality of the lacrimal duct (HP:0011481) | 5.04542435 |
16 | Natal tooth (HP:0000695) | 5.01045777 |
17 | Milia (HP:0001056) | 4.84308807 |
18 | Retrobulbar optic neuritis (HP:0100654) | 4.81733702 |
19 | Optic neuritis (HP:0100653) | 4.81733702 |
20 | Palmoplantar hyperkeratosis (HP:0000972) | 4.80667537 |
21 | Decreased lacrimation (HP:0000633) | 4.72154800 |
22 | Fragile nails (HP:0001808) | 4.51530199 |
23 | Parakeratosis (HP:0001036) | 4.50606028 |
24 | Palmar hyperkeratosis (HP:0010765) | 4.50437680 |
25 | Stomatitis (HP:0010280) | 4.47364816 |
26 | Abnormality of the nasolacrimal system (HP:0000614) | 4.35731521 |
27 | Microretrognathia (HP:0000308) | 4.35360332 |
28 | Mixed hearing impairment (HP:0000410) | 4.29315379 |
29 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.27455659 |
30 | Increased IgE level (HP:0003212) | 4.25539394 |
31 | Recurrent skin infections (HP:0001581) | 4.17901641 |
32 | Congenital ichthyosiform erythroderma (HP:0007431) | 4.16605069 |
33 | Preauricular pit (HP:0004467) | 4.09339332 |
34 | Periauricular skin pits (HP:0100277) | 4.09339332 |
35 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 4.05934779 |
36 | Abnormality of nail color (HP:0100643) | 4.02475003 |
37 | Recurrent fungal infections (HP:0002841) | 3.97998255 |
38 | Pili torti (HP:0003777) | 3.96002782 |
39 | Mediastinal lymphadenopathy (HP:0100721) | 3.92699362 |
40 | Abnormality of secondary sexual hair (HP:0009888) | 3.90967509 |
41 | Abnormality of the axillary hair (HP:0100134) | 3.90967509 |
42 | Chronic obstructive pulmonary disease (HP:0006510) | 3.87195115 |
43 | Obstructive lung disease (HP:0006536) | 3.87195115 |
44 | Advanced eruption of teeth (HP:0006288) | 3.84286175 |
45 | Spontaneous hematomas (HP:0007420) | 3.78775118 |
46 | Atrophic scars (HP:0001075) | 3.75760315 |
47 | Skin pits (HP:0100276) | 3.73449051 |
48 | Gastrointestinal infarctions (HP:0005244) | 3.68134188 |
49 | Meningitis (HP:0001287) | 3.63490058 |
50 | Urticaria (HP:0001025) | 3.58780929 |
51 | Keratoconjunctivitis sicca (HP:0001097) | 3.58294336 |
52 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.52465257 |
53 | Recurrent cutaneous fungal infections (HP:0011370) | 3.52465257 |
54 | Nail dystrophy (HP:0008404) | 3.50959142 |
55 | Gingivitis (HP:0000230) | 3.49365651 |
56 | Abnormality of the gastric mucosa (HP:0004295) | 3.48812892 |
57 | Sparse scalp hair (HP:0002209) | 3.46060122 |
58 | Ventricular fibrillation (HP:0001663) | 3.44843973 |
59 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.44359649 |
60 | Scapular winging (HP:0003691) | 3.36946487 |
61 | Prolonged bleeding time (HP:0003010) | 3.34384648 |
62 | Erythema (HP:0010783) | 3.34020538 |
63 | Encephalitis (HP:0002383) | 3.30334231 |
64 | Keratoconjunctivitis (HP:0001096) | 3.29157785 |
65 | Ventricular tachycardia (HP:0004756) | 3.27793437 |
66 | Amyloidosis (HP:0011034) | 3.17181231 |
67 | Sparse eyelashes (HP:0000653) | 3.13093304 |
68 | Abnormal blistering of the skin (HP:0008066) | 3.08236883 |
69 | Vasculitis (HP:0002633) | 3.07258438 |
70 | Increased cerebral lipofuscin (HP:0011813) | 3.05875750 |
71 | Ectropion (HP:0000656) | 3.03356660 |
72 | Oligodontia (HP:0000677) | 3.02166960 |
73 | Abnormality of glycolipid metabolism (HP:0010969) | 3.00631165 |
74 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.00631165 |
75 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.00631165 |
76 | Cellulitis (HP:0100658) | 2.96306008 |
77 | Episodic fever (HP:0001954) | 2.92885894 |
78 | Gingival bleeding (HP:0000225) | 2.91542019 |
79 | Hemoptysis (HP:0002105) | 2.91048608 |
80 | Chest pain (HP:0100749) | 2.85209727 |
81 | Pulmonary infiltrates (HP:0002113) | 2.83804315 |
82 | Abnormality of the antihelix (HP:0009738) | 2.81894798 |
83 | Epistaxis (HP:0000421) | 2.70942789 |
84 | Arterial thrombosis (HP:0004420) | 2.69964928 |
85 | Hypochromic microcytic anemia (HP:0004840) | 2.68006504 |
86 | T lymphocytopenia (HP:0005403) | 2.64495591 |
87 | Erythroderma (HP:0001019) | 2.63708591 |
88 | Petechiae (HP:0000967) | 2.63510554 |
89 | Pterygium (HP:0001059) | 2.62855375 |
90 | Leukocytosis (HP:0001974) | 2.61965755 |
91 | Recurrent viral infections (HP:0004429) | 2.59599090 |
92 | Hypoplasia of dental enamel (HP:0006297) | 2.59021734 |
93 | Purpura (HP:0000979) | 2.58909845 |
94 | Pulmonary embolism (HP:0002204) | 2.58062774 |
95 | Peritonitis (HP:0002586) | 2.56951495 |
96 | Inflammation of the large intestine (HP:0002037) | 2.55572655 |
97 | Abnormality of T cell number (HP:0011839) | 2.49607253 |
98 | Aplasia cutis congenita (HP:0001057) | 2.47930073 |
99 | Loss of speech (HP:0002371) | 2.47610722 |
100 | Hypochromic anemia (HP:0001931) | 2.47197405 |
101 | Gastrointestinal inflammation (HP:0004386) | 2.45224276 |
102 | Osteomyelitis (HP:0002754) | 2.44552689 |
103 | Selective tooth agenesis (HP:0001592) | 2.44438474 |
104 | Anhidrosis (HP:0000970) | 2.41710053 |
105 | Anorexia (HP:0002039) | 2.39369932 |
106 | Hypohidrosis (HP:0000966) | 2.38428804 |
107 | Hypergammaglobulinemia (HP:0010702) | 2.37027517 |
108 | Palmoplantar keratoderma (HP:0000982) | 2.36683905 |
109 | Abnormal hair laboratory examination (HP:0003328) | 2.35687884 |
110 | Dysostosis multiplex (HP:0000943) | 2.34958036 |
111 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.29280510 |
112 | Popliteal pterygium (HP:0009756) | 2.26893056 |
113 | Sepsis (HP:0100806) | 2.24687903 |
114 | Panhypogammaglobulinemia (HP:0003139) | 2.23693490 |
115 | Corneal erosion (HP:0200020) | 2.18277229 |
116 | Hematochezia (HP:0002573) | 2.17727825 |
117 | Fragile skin (HP:0001030) | 2.16829561 |
118 | Vacuolated lymphocytes (HP:0001922) | 2.16440524 |
119 | Disinhibition (HP:0000734) | 2.15147215 |
120 | Intellectual disability, moderate (HP:0002342) | 2.13751126 |
121 | Abnormality of proline metabolism (HP:0010907) | 2.13144773 |
122 | Hydroxyprolinuria (HP:0003080) | 2.13144773 |
123 | Increased serum ferritin (HP:0003281) | 2.11501527 |
124 | Abnormality of T cells (HP:0002843) | 2.11409969 |
125 | Skin ulcer (HP:0200042) | 2.10901401 |
126 | Increased IgM level (HP:0003496) | 2.10441010 |
127 | Colitis (HP:0002583) | 2.10140341 |
128 | Prostate neoplasm (HP:0100787) | 2.07770382 |
129 | Pruritus (HP:0000989) | 2.07031918 |
130 | Esophageal atresia (HP:0002032) | 2.06252576 |
131 | Chronic otitis media (HP:0000389) | 2.05937736 |
132 | Abnormality of the pleura (HP:0002103) | 2.05930652 |
133 | Hypoplastic labia majora (HP:0000059) | 2.05356062 |
134 | Hepatosplenomegaly (HP:0001433) | 2.05341892 |
135 | Vertigo (HP:0002321) | 2.04534002 |
136 | Pustule (HP:0200039) | 2.03980590 |
137 | Systemic lupus erythematosus (HP:0002725) | 2.03732084 |
138 | Testicular atrophy (HP:0000029) | 2.03208818 |
139 | Granulocytopenia (HP:0001913) | 2.02688717 |
140 | Abnormal platelet volume (HP:0011876) | 2.02292603 |
141 | Hyporeflexia of lower limbs (HP:0002600) | 2.02140500 |
142 | Acanthosis nigricans (HP:0000956) | 2.01346729 |
143 | Premature loss of primary teeth (HP:0006323) | 1.99286859 |
144 | Eczematoid dermatitis (HP:0000976) | 1.99104933 |
145 | Acne (HP:0001061) | 1.97558419 |
146 | Periodontitis (HP:0000704) | 1.95577132 |
147 | Malnutrition (HP:0004395) | 1.95317508 |
148 | Microcytic anemia (HP:0001935) | 1.94468231 |
149 | Dehydration (HP:0001944) | 1.93538656 |
150 | Absent hair (HP:0002298) | 1.93436700 |
151 | Polyneuropathy (HP:0001271) | 1.92817253 |
152 | Abnormality of the peritoneum (HP:0002585) | 1.92284348 |
153 | Hypodontia (HP:0000668) | 1.91604105 |
154 | Villous atrophy (HP:0011473) | 1.90226982 |
155 | Abnormality of small intestinal villus morphology (HP:0011472) | 1.90226982 |
156 | Absent eyebrow (HP:0002223) | 1.89983745 |
157 | Ventricular arrhythmia (HP:0004308) | 1.89322128 |
158 | Abnormality of the endocardium (HP:0004306) | 1.88948388 |
159 | Glomerulopathy (HP:0100820) | 1.88563511 |
160 | Abnormality of iron homeostasis (HP:0011031) | 1.88471657 |
161 | Tapered finger (HP:0001182) | 1.87446744 |
162 | Abnormality of the labia majora (HP:0012881) | 1.85095864 |
163 | Ureteral stenosis (HP:0000071) | 1.85092073 |
164 | Gangrene (HP:0100758) | 1.84566689 |
165 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.83815111 |
166 | Absent eyelashes (HP:0000561) | 1.83706289 |
167 | Lymphopenia (HP:0001888) | 1.83328799 |
168 | Slow saccadic eye movements (HP:0000514) | 1.83239894 |
169 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.82324382 |
170 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.82324382 |
171 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.82324382 |
172 | Ureteral obstruction (HP:0006000) | 1.81596475 |
173 | Keratitis (HP:0000491) | 1.80813478 |
174 | Hypermelanotic macule (HP:0001034) | 1.78967639 |
175 | Polycythemia (HP:0001901) | 1.78957556 |
176 | Neonatal death (HP:0003811) | 1.78481765 |
177 | Dry hair (HP:0011359) | 1.76725367 |
178 | Cheilitis (HP:0100825) | 1.75951045 |
179 | Autoimmune thrombocytopenia (HP:0001973) | 1.75289178 |
180 | Curly hair (HP:0002212) | 1.73483714 |
181 | Malignant hyperthermia (HP:0002047) | 1.72970178 |
182 | Hoarse voice (HP:0001609) | 1.65023883 |
183 | Abnormality of the shoulder girdle musculature (HP:0001435) | 1.63332857 |
184 | Premature skin wrinkling (HP:0100678) | 1.63196801 |
185 | Sudden cardiac death (HP:0001645) | 1.61886507 |
186 | Morphological abnormality of the middle ear (HP:0008609) | 1.61761490 |
187 | Thick nail (HP:0001805) | 1.58259778 |
188 | Amelogenesis imperfecta (HP:0000705) | 1.57105907 |
189 | Interstitial pulmonary disease (HP:0006530) | 1.57019450 |
190 | Fatigable weakness (HP:0003473) | 1.55559804 |
191 | Abnormality of the neuromuscular junction (HP:0003398) | 1.55559804 |
192 | Anonychia (HP:0001798) | 1.54861796 |
193 | Dry skin (HP:0000958) | 1.53920538 |
194 | Ridged nail (HP:0001807) | 1.53872142 |
Rank | Gene Set | Z-score |
---|---|---|
1 | LATS1 | 4.54801482 |
2 | MAPK15 | 4.47704769 |
3 | MST4 | 4.25625299 |
4 | FER | 3.75925160 |
5 | MAP4K1 | 3.15341245 |
6 | RPS6KB2 | 2.98840741 |
7 | MAPKAPK3 | 2.96201320 |
8 | MAP2K3 | 2.93870795 |
9 | CSK | 2.87817354 |
10 | PRPF4B | 2.87337613 |
11 | FES | 2.70714306 |
12 | MAP3K3 | 2.65946953 |
13 | TNK2 | 2.61781040 |
14 | IRAK4 | 2.59907690 |
15 | MAP3K2 | 2.43614707 |
16 | ZAP70 | 2.13280000 |
17 | TTN | 2.11224883 |
18 | ERN1 | 2.01187313 |
19 | FGR | 2.00273396 |
20 | PTK6 | 2.00073512 |
21 | FGFR4 | 1.96354787 |
22 | EPHB1 | 1.92516360 |
23 | MAP3K14 | 1.90422880 |
24 | GRK6 | 1.89489672 |
25 | BCR | 1.74319241 |
26 | EPHB2 | 1.70509295 |
27 | HCK | 1.69683633 |
28 | TAOK1 | 1.67472016 |
29 | SYK | 1.64476418 |
30 | TYK2 | 1.56676676 |
31 | DYRK1B | 1.55331935 |
32 | MAP3K11 | 1.49026049 |
33 | EPHA3 | 1.46676276 |
34 | MAPKAPK5 | 1.46322782 |
35 | TXK | 1.42293173 |
36 | MST1R | 1.41320695 |
37 | ITK | 1.39784868 |
38 | ERBB3 | 1.38865329 |
39 | CSF1R | 1.34695269 |
40 | LYN | 1.32647358 |
41 | TSSK6 | 1.32456929 |
42 | RIPK4 | 1.31142602 |
43 | BTK | 1.30680413 |
44 | YES1 | 1.28070488 |
45 | LMTK2 | 1.27999144 |
46 | SIK3 | 1.27010522 |
47 | ERBB2 | 1.26618255 |
48 | LATS2 | 1.26005971 |
49 | GRK1 | 1.25873109 |
50 | KSR2 | 1.21622780 |
51 | FGFR2 | 1.19486846 |
52 | MARK2 | 1.18562863 |
53 | LCK | 1.14670091 |
54 | MAP3K6 | 1.14445918 |
55 | IKBKE | 1.13853088 |
56 | KIT | 1.10419429 |
57 | MARK3 | 1.08856620 |
58 | TAOK3 | 1.08117326 |
59 | MAPKAPK2 | 1.07433963 |
60 | TBK1 | 1.02969568 |
61 | MATK | 1.00246424 |
62 | STK38L | 0.99779549 |
63 | PDK1 | 0.98440134 |
64 | PDPK1 | 0.97864625 |
65 | JAK1 | 0.95190885 |
66 | TRPM7 | 0.95083493 |
67 | MAPK12 | 0.94960874 |
68 | PRKD2 | 0.93863933 |
69 | EEF2K | 0.93851992 |
70 | PIK3CG | 0.92270725 |
71 | TRIB3 | 0.90844363 |
72 | FGFR3 | 0.90029720 |
73 | JAK2 | 0.89390360 |
74 | MAPK7 | 0.88848274 |
75 | STK10 | 0.86606342 |
76 | LRRK2 | 0.83865900 |
77 | CHUK | 0.83723748 |
78 | PIM2 | 0.83612363 |
79 | TGFBR2 | 0.81528820 |
80 | TESK1 | 0.81482693 |
81 | PTK2 | 0.80659858 |
82 | SIK1 | 0.79839191 |
83 | MAP2K2 | 0.79196883 |
84 | TAOK2 | 0.77793919 |
85 | PAK2 | 0.76965172 |
86 | CLK1 | 0.75479135 |
87 | CDC42BPA | 0.74193182 |
88 | FYN | 0.73895523 |
89 | CAMKK2 | 0.73715462 |
90 | IRAK2 | 0.73369413 |
91 | MAP2K4 | 0.71201460 |
92 | CDK3 | 0.71134254 |
93 | MAP3K7 | 0.70968820 |
94 | CAMK2G | 0.70911614 |
95 | IRAK1 | 0.69774775 |
96 | RIPK1 | 0.68027866 |
97 | SGK3 | 0.67677169 |
98 | GRK7 | 0.67299205 |
99 | CDK19 | 0.65719923 |
100 | BMPR2 | 0.64619597 |
101 | PKN1 | 0.63533358 |
102 | STK11 | 0.60303967 |
103 | TGFBR1 | 0.59824813 |
104 | SIK2 | 0.58324318 |
105 | PRKCE | 0.56627929 |
106 | TESK2 | 0.55411066 |
107 | FRK | 0.54880808 |
108 | RPS6KA1 | 0.54679643 |
109 | TEC | 0.52336390 |
110 | PAK3 | 0.50647782 |
111 | IRAK3 | 0.49409079 |
112 | MAP3K5 | 0.48968191 |
113 | CAMKK1 | 0.48615416 |
114 | IKBKB | 0.48513422 |
115 | PTK2B | 0.47498141 |
116 | NLK | 0.47386834 |
117 | RET | 0.47312954 |
118 | STK3 | 0.47126980 |
119 | SGK2 | 0.47094537 |
120 | JAK3 | 0.46711223 |
121 | PRKCQ | 0.46568882 |
122 | MAP3K13 | 0.46511370 |
123 | DMPK | 0.45919484 |
124 | FGFR1 | 0.45886927 |
125 | SMG1 | 0.44425914 |
126 | DAPK2 | 0.44354576 |
127 | KSR1 | 0.43012158 |
128 | MOS | 0.42133824 |
129 | PDGFRB | 0.41708569 |
130 | MAP3K1 | 0.41593562 |
131 | CSNK1D | 0.41395124 |
132 | CAMK1D | 0.41030246 |
133 | PRKD1 | 0.41019376 |
134 | STK38 | 0.40350879 |
135 | ROCK2 | 0.38966531 |
136 | PIK3CA | 0.38629408 |
137 | NUAK1 | 0.38284139 |
138 | RPS6KA2 | 0.37593242 |
139 | HIPK2 | 0.37081309 |
140 | SRC | 0.36820043 |
141 | NEK6 | 0.35920116 |
142 | RPS6KC1 | 0.35527936 |
143 | RPS6KL1 | 0.35527936 |
144 | MAP3K9 | 0.34809306 |
145 | DDR2 | 0.34278914 |
146 | MAP2K6 | 0.33127513 |
147 | BLK | 0.32848556 |
148 | RPS6KA6 | 0.32111549 |
149 | RAF1 | 0.31669557 |
150 | RPS6KA5 | 0.31575322 |
151 | PRKCI | 0.31502775 |
152 | NME1 | 0.31233168 |
153 | GRK5 | 0.30587246 |
154 | PDGFRA | 0.28018447 |
155 | MYLK | 0.27425140 |
156 | ADRBK1 | 0.27408972 |
157 | ABL1 | 0.27360589 |
158 | CAMK2B | 0.26713433 |
159 | MAPK3 | 0.26602751 |
160 | GSK3A | 0.26329716 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 3.63187233 |
2 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 2.84818227 |
3 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.56956462 |
4 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 2.49916821 |
5 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 2.39612419 |
6 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 2.21291526 |
7 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 2.17907301 |
8 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.14197201 |
9 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 2.12341066 |
10 | Allograft rejection_Homo sapiens_hsa05330 | 2.11660622 |
11 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.09281393 |
12 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.08687594 |
13 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 2.08114086 |
14 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 2.06340015 |
15 | Histidine metabolism_Homo sapiens_hsa00340 | 2.00834769 |
16 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.97211121 |
17 | Other glycan degradation_Homo sapiens_hsa00511 | 1.87211427 |
18 | Malaria_Homo sapiens_hsa05144 | 1.79621567 |
19 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.71876839 |
20 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.70868839 |
21 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.67565038 |
22 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.67355890 |
23 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.65786499 |
24 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.61376710 |
25 | Hippo signaling pathway_Homo sapiens_hsa04390 | 1.55217322 |
26 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.54521988 |
27 | Viral myocarditis_Homo sapiens_hsa05416 | 1.46264361 |
28 | Adherens junction_Homo sapiens_hsa04520 | 1.44524709 |
29 | Asthma_Homo sapiens_hsa05310 | 1.41170323 |
30 | Tight junction_Homo sapiens_hsa04530 | 1.30588304 |
31 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.29920515 |
32 | Platelet activation_Homo sapiens_hsa04611 | 1.29840104 |
33 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 1.24923098 |
34 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.24916418 |
35 | Basal cell carcinoma_Homo sapiens_hsa05217 | 1.24475409 |
36 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.24392021 |
37 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.20716937 |
38 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.20593264 |
39 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.16526069 |
40 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.14318766 |
41 | Amoebiasis_Homo sapiens_hsa05146 | 1.14023161 |
42 | Pertussis_Homo sapiens_hsa05133 | 1.13762759 |
43 | Axon guidance_Homo sapiens_hsa04360 | 1.13372116 |
44 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.12720669 |
45 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.11905244 |
46 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.10438727 |
47 | Leishmaniasis_Homo sapiens_hsa05140 | 1.09545669 |
48 | Hepatitis C_Homo sapiens_hsa05160 | 1.07847490 |
49 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.06628359 |
50 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.05646429 |
51 | Salmonella infection_Homo sapiens_hsa05132 | 1.04655648 |
52 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.04243451 |
53 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.03638071 |
54 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.03324427 |
55 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.02348515 |
56 | Hepatitis B_Homo sapiens_hsa05161 | 1.02146815 |
57 | ABC transporters_Homo sapiens_hsa02010 | 1.01598009 |
58 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.00651532 |
59 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.00138969 |
60 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.99967679 |
61 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.95807513 |
62 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.95243977 |
63 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.94251321 |
64 | Shigellosis_Homo sapiens_hsa05131 | 0.92872873 |
65 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.91072819 |
66 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.90974628 |
67 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.90059796 |
68 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.87599028 |
69 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.87020967 |
70 | Lysosome_Homo sapiens_hsa04142 | 0.86567112 |
71 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.86464368 |
72 | Influenza A_Homo sapiens_hsa05164 | 0.84144410 |
73 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.83876616 |
74 | Endocytosis_Homo sapiens_hsa04144 | 0.83532620 |
75 | Focal adhesion_Homo sapiens_hsa04510 | 0.83481887 |
76 | Bladder cancer_Homo sapiens_hsa05219 | 0.82239869 |
77 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.81736277 |
78 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.80408781 |
79 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.79525056 |
80 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.76895554 |
81 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.75530089 |
82 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.74645530 |
83 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.74370951 |
84 | Melanogenesis_Homo sapiens_hsa04916 | 0.73953359 |
85 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.73125647 |
86 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.71767453 |
87 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.69352598 |
88 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.68607906 |
89 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.68165769 |
90 | Endometrial cancer_Homo sapiens_hsa05213 | 0.67131097 |
91 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.66292160 |
92 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.66208306 |
93 | Insulin resistance_Homo sapiens_hsa04931 | 0.66044546 |
94 | Pathways in cancer_Homo sapiens_hsa05200 | 0.65066995 |
95 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.64726704 |
96 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.64698373 |
97 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.64216475 |
98 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.63726263 |
99 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.63265655 |
100 | Legionellosis_Homo sapiens_hsa05134 | 0.63073338 |
101 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.62905625 |
102 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.62273634 |
103 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.61127898 |
104 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.60358622 |
105 | Apoptosis_Homo sapiens_hsa04210 | 0.60270053 |
106 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.59566671 |
107 | Retinol metabolism_Homo sapiens_hsa00830 | 0.59224793 |
108 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.58864702 |
109 | Mineral absorption_Homo sapiens_hsa04978 | 0.58820579 |
110 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.58761462 |
111 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.58401290 |
112 | Tuberculosis_Homo sapiens_hsa05152 | 0.58361058 |
113 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.57798358 |
114 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.55447471 |
115 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.55398608 |
116 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.54733600 |
117 | Measles_Homo sapiens_hsa05162 | 0.53254157 |
118 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.52961959 |
119 | Colorectal cancer_Homo sapiens_hsa05210 | 0.52944597 |
120 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.50793647 |
121 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.50733829 |
122 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.50463159 |
123 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.50326309 |
124 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.49966834 |
125 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.49940267 |
126 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.48934343 |
127 | Prostate cancer_Homo sapiens_hsa05215 | 0.48698885 |
128 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.48578398 |
129 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.48222328 |
130 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.48148615 |
131 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.47917369 |
132 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.47559086 |
133 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.46494649 |
134 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.46187094 |
135 | HTLV-I infection_Homo sapiens_hsa05166 | 0.45927802 |
136 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.44707924 |
137 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.43166522 |
138 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.42507518 |
139 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.42099963 |
140 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.41911689 |
141 | Melanoma_Homo sapiens_hsa05218 | 0.41516566 |
142 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.41462277 |
143 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.41206123 |
144 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.40716253 |
145 | Phagosome_Homo sapiens_hsa04145 | 0.40560892 |
146 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.40457924 |
147 | Long-term potentiation_Homo sapiens_hsa04720 | 0.39108701 |
148 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.38909657 |
149 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.38855769 |
150 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.38777862 |
151 | Cocaine addiction_Homo sapiens_hsa05030 | 0.37749480 |